Bjørn Henning Grønberg

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

Annika Malmström, Bjørn Henning Grønberg, Christine Marosi et al. · The Lancet Oncology · 2012 · 1.3K citations

Medicine, Oncology, Radiation Oncology +12

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Bjørn Henning Grønberg, Roy M. Bremnes, Øystein Fløtten et al. · Journal of Clinical Oncology · 2009 · 290 citations · Full text

Medicine, Oncology, Pharmacology +16

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer

Guro B. Stene, Jorunn L. Helbostad, Tore Amundsen et al. · Acta Oncologica · 2014 · 215 citations · Full text

Medicine, Oncology, Radiology +17

Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty

Lene Kirkhus, Jūratė Šaltytė Benth, Siri Rostoft et al. · British Journal of Cancer · 2017 · 154 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Muscle mass and association to quality of life in non‐small cell lung cancer patients

Asta Bye, Bjørg Sjøblom, Tore Wentzel‐Larsen et al. · Journal of Cachexia Sarcopenia and Muscle · 2017 · 147 citations · Full text

Medicine, Oncology, Radiology +14